Literature DB >> 20517905

Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before.

Yasuhiro Ogura1, Tomohide Hori, Walid M El Moghazy, Atsushi Yoshizawa, Fumitaka Oike, Akira Mori, Toshimi Kaido, Yasutsugu Takada, Shinji Uemoto.   

Abstract

To prevent small-for-size syndrome in adult-to-adult living donor liver transplantation (A-LDLT), larger grafts (ie, right lobe grafts) have been selected in many transplant centers. However, some centers are investigating the benefits of portal pressure modulation. Five hundred sixty-six A-LDLT procedures using right or left lobe grafts were performed between 1998 and 2008. In 2006, we introduced intentional portal pressure control, and we changed the graft selection criteria to include a graft/recipient weight ratio >0.7% instead of the original value of >0.8%. All recipients were divided into period I (1998-2006, the era of unintentional portal pressure control; n = 432) and period II (2006-2008, the era of intentional portal pressure control; n = 134). The selection of small-for-size grafts increased from 7.8% to 23.9%, and the selection of left lobe grafts increased from 4.9% to 32.1%. Despite the increase in the number of smaller grafts in period II, 1-year patient survival was significantly improved (87.9% versus 76.2%). In 129 recipients in period II, portal pressure was monitored. Patients with a portal pressure <15 mm Hg demonstrated better 2-year survival (n = 86, 93.0%) than patients with a portal pressure >or=15 mm Hg (n = 43, 66.3%). The recovery from hyperbilirubinemia and coagulopathy after transplantation was significantly better in patients with a portal pressure <15 mm Hg. In conclusion, our strategy for A-LDLT has changed from larger graft-based A-LDLT to controlled portal pressure-based A-LDLT with smaller grafts. A portal pressure <15 mm Hg seems to be a key for successful A-LDLT. (c) 2010 AASLD.

Entities:  

Mesh:

Year:  2010        PMID: 20517905     DOI: 10.1002/lt.22059

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  51 in total

Review 1.  [Small-for-size: experimental findings for liver surgery].

Authors:  C Eipel; K Abshagen; B Vollmar
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

2.  Left-sided grafts for living-donor liver transplantation and split grafts for deceased-donor liver transplantation: their impact on long-term survival.

Authors:  Tomohide Hori; Shinji Uemoto; Lindsay B Gardner; Lena Sibulesky; Yasuhiro Ogura; Justin H Nguyen
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-09-28       Impact factor: 2.947

3.  Hepatobiliary quiz-3 (2012).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2012-09

Review 4.  Review of the surgical approach to prevent small-for-size syndrome in recipients after left lobe adult LDLT.

Authors:  Vikram Raut; Ruslan Alikhanov; Jacques Belghiti; Shinji Uemoto
Journal:  Surg Today       Date:  2013-08-01       Impact factor: 2.549

Review 5.  Portosystemic Shunts for "Too Small-for-Size Syndrome" After Liver Transplantation: A Systematic Review.

Authors:  Erdem Kinaci; Cuneyt Kayaalp
Journal:  World J Surg       Date:  2016-08       Impact factor: 3.352

6.  Younger Age is an Independent Factor for Graft Weight Overestimation: Analysis of the Clinical Impact on Recipient Outcomes in 340 Japanese Living Liver Donors.

Authors:  Toshihiro Kitajima; Toshimi Kaido; Tetsuya Tajima; Tadahiro Uemura; Yasuhiro Fujimoto; Andrea Schenk; Shinji Uemoto
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

7.  Hemodynamics and vasoactive substance levels during renal congestion that occurs in the anhepatic phase of liver transplantation.

Authors:  Zhong-Xin Li; Man-Cai Wang; You-Cheng Zhang; Jie Mao; Mo Chen; Rui Ni; Feng-Xian Wei; Gen-Nian Wang; Ling-Yi Zhang
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

8.  Etiologies, risk factors, and outcomes of bacterial cholangitis after living donor liver transplantation.

Authors:  Siyuan Yao; Shintaro Yagi; Miki Nagao; Ryuji Uozumi; Taku Iida; Sena Iwamura; Yosuke Miyachi; Hisaya Shirai; Atsushi Kobayashi; Shinya Okumura; Yuhei Hamaguchi; Yuuki Masano; Toshimi Kaido; Hideaki Okajima; Shinji Uemoto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-23       Impact factor: 3.267

9.  Hepatic Hemodynamics and Portal Flow Modulation: The A2ALL Experience.

Authors:  Jean C Emond; Nathan P Goodrich; James J Pomposelli; Talia B Baker; Abhinav Humar; David R Grant; Peter Abt; Chris E Friese; Robert A Fisher; Igal Kam; Averell H Sherker; Brenda W Gillespie; Robert M Merion
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

Review 10.  Systemic hemodynamics in advanced cirrhosis: Concerns during perioperative period of liver transplantation.

Authors:  Tomohide Hori; Yasuhiro Ogura; Yasuharu Onishi; Hideya Kamei; Nobuhiko Kurata; Motoshi Kainuma; Hideo Takahashi; Shogo Suzuki; Takashi Ichikawa; Shoko Mizuno; Tadashi Aoyama; Yuki Ishida; Takahiro Hirai; Tomoko Hayashi; Kazuko Hasegawa; Hiromu Takeichi; Atsunobu Ota; Yasuhiro Kodera; Hiroyuki Sugimoto; Taku Iida; Shintaro Yagi; Kentaro Taniguchi; Shinji Uemoto
Journal:  World J Hepatol       Date:  2016-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.